Furthermore, Western blot analysis showed that Ad-ANGPTL4 treatment could inhibit the expression of VEGF protein and phosphorylation of Raf-MEK-Erk signaling pathway of HCC (Figure 5C). The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.